Clinical Trial Update: Safety and Performance Study of the CardioGard Cannula [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 safety and performance study of the CardioGard Cannula for use in aortic valve replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• CARDIOGARD Cannula

Snippet

Sponsor: CardioGard Medical Ltd. | Conditions: Aortic Valve Replacement | Phase 2, Phase 3 | Status: COMPLETED